Figure 6
From: Novel antiviral activity of baicalein against dengue virus
Anti-dengue effect of continuous treatment with baicalein. Foci forming unit reduction assay was used to evaluate the in vitro anti-dengue virus activities of the baicalein (A). The respective DENV-2 RNA copy number was quantified using qRT-PCR (B). The percentages of foci reduction (%RF) and RNA copy number reduction were obtained by comparing against untreated controls maintained in parallel.